1. Home
  2. TFX vs ALKS Comparison

TFX vs ALKS Comparison

Compare TFX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$112.99

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$29.63

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFX
ALKS
Founded
1943
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
TFX
ALKS
Price
$112.99
$29.63
Analyst Decision
Hold
Strong Buy
Analyst Count
10
13
Target Price
$139.88
$42.85
AVG Volume (30 Days)
732.0K
1.7M
Earning Date
02-26-2026
02-11-2026
Dividend Yield
1.24%
N/A
EPS Growth
N/A
2.44
EPS
N/A
2.02
Revenue
$3,189,988,000.00
$1,521,338,000.00
Revenue This Year
$9.90
N/A
Revenue Next Year
$10.51
$24.22
P/E Ratio
N/A
$14.71
Revenue Growth
5.42
1.08
52 Week Low
$102.58
$25.17
52 Week High
$185.94
$36.45

Technical Indicators

Market Signals
Indicator
TFX
ALKS
Relative Strength Index (RSI) 38.05 59.88
Support Level $108.39 $27.50
Resistance Level $127.49 $28.63
Average True Range (ATR) 3.20 0.74
MACD -1.33 0.23
Stochastic Oscillator 24.64 75.25

Price Performance

Historical Comparison
TFX
ALKS

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: